Science & Technology
Sbir Fy25 Concept Award: Development of Engineered Trna Therapeutics for Clear Cell Renal Cell Carcinoma
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N91025C00020
Award Ceiling
$355K
Award Floor
$355K
Close Date
N/A
Total Funding
$355K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N91025C00020
Description
SBIR Phase Phase I award: "SBIR FY25 CONCEPT AWARD: DEVELOPMENT OF ENGINEERED TRNA THERAPEUTICS FOR CLEAR CELL RENAL CELL CARCINOMA" awarded to CLOVERLEAF BIO, INC. in NEW HAVEN, Connecticut. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $355,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.